At Compamed 2017 in Düsseldorf, Germany, Covestro will be presenting itself as a key supplier of raw materials and partner to the medical technology sector. One focus of booth H30 in Hall 8b will be on Baymedixpolyurethane raw materials for state-of-the-art wound care. These materials are breathable and enable optimal moisture management in wound dressings in addition to offering design options. Customers can create added value through innovation and differentiation, thus increasing their competitiveness.

These raw materials are used, for example, in absorbent foams manufactured from BaymedixFP, adhesives with skin contact made of BaymedixA and films based on the waterborne products BaymedixFD and CD. Directly coating the film with adhesive or foam decreases the number of laminating steps, and optimized drying times ensure efficiency in production. The processes are also sustainable because waste is reduced and solvents are not used.

Polycarbonates for a wide range of requirements
The polycarbonate Makrolonhas long proven itself in the medical technology field. Its balanced properties - such as exceptional transparency and impact resistance - make it a safe and durable material for housing components.

Several variants of this material have also passed biocompatibility tests, as required for such applications, and thus meet the criteria of ISO 10993-1. Together with the polycarbonate Apec, which is stable at high temperatures, Makrolonmedical technology products are suitable for various forms of sterilization.

Wearables with intelligence and comfort
Digitalization is now common in many areas of medical technology. For example, one important trend is the use of wearables - small electronic devices that are affixed to the skin like a patch, providing support for consumers participating in sports and leisure activities or treating medical conditions. In view of their enormous market potential, Compamed is presenting these devices separately at booth A23 in Hall 15.

There, Covestro will showcase integrated and sustainable materials solutions that increase the comfort of electronic patches and provide additional areas of application. In addition to standard functions, such as measuring heart rate, in the future they will also help with medical diagnoses and treatments and deliver medications in accurate dosages. This would require them to remain on the skin for extended periods and be comfortable to wear. With the help of an intelligent combination of materials, Covestro is able to produce wearables that cling gently to the skin, and are also breathable and hypoallergenic.

Versatile TPU films
PlatilonTPU blown film is sought after in medical applications, due to its comfort, e.g. breathability, stretch, soft haptics, hypoallergenics, design (e.g. printable, colors) and customisation to fit the converter's production process, e.g. thickness range, tailored carriers and release force. Additional functionality includes low melting (95-105 deg C) or water vapor barrier.

About Covestro:
With 2016 sales of EUR 11.9 billion, Covestro is among the world's largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, construction, wood processing and furniture, and electrical and electronics industries. Other sectors include sports and leisure, cosmetics, health and the chemical industry itself. Covestro has 30 production sites worldwide and employs approximately 15,600 people (calculated as full-time equivalents) at the end of 2016.

Find more information atwww.covestro.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Covestro AG. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Covestro's public reports, which are available on the Covestro website atwww.covestro.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Covestro AG published this content on 21 September 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 September 2017 08:54:06 UTC.

Original documenthttp://press.covestro.com/news.nsf/id/Competent-partner-for-medical-technology

Public permalinkhttp://www.publicnow.com/view/FAAAA4D18FF04A305ECC51DD5E1117CAE55455B8